https://t.co/wftXxxfG94 buena revision de mecanismos aunque todavía no sabemos cual predomina más...
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @elendocrino: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects | SpringerLink https://t.co/oRARd8p…
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @sball_endo: Cardiovascular benefits of Empagliflozin. https://t.co/TS3v1IZNWl
Cardiovascular benefits of Empagliflozin. https://t.co/TS3v1IZNWl
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @elendocrino: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects | SpringerLink https://t.co/oRARd8p…
RT @elendocrino: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects | SpringerLink https://t.co/oRARd8p…
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects | SpringerLink https://t.co/0xeRUbBTrx https://t.co/2g2MWdRASD
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects | SpringerLink https://t.co/oRARd8p2gy https://t.co/0eg3bZSQF5
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @Foroactua: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/BJyt0hYDhF https://t.co…
RT @Foroactua: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/BJyt0hYDhF https://t.co…
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
The CV benefits of Empagliflozin. All we need to know. https://t.co/24rQgKMdrG
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/BJyt0hYDhF https://t.co/voUnLXnRWD https://t.co/lLwTlQid8x
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
RT @DiabetologiaJnl: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/1MEcteKxzO
https://t.co/AAYAMqAQFy: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent ef... https://t.co/7EKTTmzizE
https://t.co/AAYAMqAQFy: The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent ef... https://t.co/7EKTTmzizE
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/ordG3VmNxn
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/LYxfjiIZPy
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/3VeJYQjSZJ
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/0Ow9RgR0TN
RT @Office_j: 【雑記】Diabetologia誌に,SGLT2阻害薬による心保護作用に関する総説。エネルギー代謝改善に加え,直接的心筋保護作用にも言及。 https://t.co/JNjpHIf96m https://t.co/QZuQaeE27w
RT @syuichiao89: SGLT-2はDM治療薬でありながら、実際には擬似的にDMを誘発し、エネルギー損失をもたらすと、まあ尿糖出るわけですからね。それがミトコンドリアでの生合成をアクティブにして、擬似的に食事制限や運動をしたような状態にしているかもと。https:/…
RT @syuichiao89: SGLT-2はDM治療薬でありながら、実際には擬似的にDMを誘発し、エネルギー損失をもたらすと、まあ尿糖出るわけですからね。それがミトコンドリアでの生合成をアクティブにして、擬似的に食事制限や運動をしたような状態にしているかもと。https:/…
SGLT-2はDM治療薬でありながら、実際には擬似的にDMを誘発し、エネルギー損失をもたらすと、まあ尿糖出るわけですからね。それがミトコンドリアでの生合成をアクティブにして、擬似的に食事制限や運動をしたような状態にしているかもと。https://t.co/YRyudyxlLl
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects https://t.co/YRyudyxlLl
RT @Office_j: 【雑記】Diabetologia誌に,SGLT2阻害薬による心保護作用に関する総説。エネルギー代謝改善に加え,直接的心筋保護作用にも言及。 https://t.co/JNjpHIf96m https://t.co/QZuQaeE27w
RT @Office_j: 【雑記】Diabetologia誌に,SGLT2阻害薬による心保護作用に関する総説。エネルギー代謝改善に加え,直接的心筋保護作用にも言及。 https://t.co/JNjpHIf96m https://t.co/QZuQaeE27w
RT @Office_j: 【雑記】Diabetologia誌に,SGLT2阻害薬による心保護作用に関する総説。エネルギー代謝改善に加え,直接的心筋保護作用にも言及。 https://t.co/JNjpHIf96m https://t.co/QZuQaeE27w
【雑記】Diabetologia誌に,SGLT2阻害薬による心保護作用に関する総説。エネルギー代謝改善に加え,直接的心筋保護作用にも言及。 https://t.co/JNjpHIf96m https://t.co/QZuQaeE27w